Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Otonomy
6275 Nancy Ridge Drive, Suite 100
San Diego, CA 92121
Phone: 858-242-5200
www.otonomy.com

Otonomy is a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the ear. Otonomy's proprietary technology provides sustained exposure of drugs to the middle and inner ear following a single intratympanic (IT) injection. Otonomy has two product candidates in clinical development. OTO-104 is a steroid that has completed a Phase 1b clinical trial in Meniere's disease patients. OTO-201 is an antibiotic that has recently completed a Phase 1b clinical trial in pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. Otonomy is advancing both OTO-104 and OTO-201 into late-stage clinical trials. Additional product candidates are expected to target tinnitus and chronic forms of hearing loss.

Key Contact
Name
David A. Weber
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
09/04/13 $45,900,000 Series C Aperture Venture Partners
Avalon Ventures
Domain Associates
Novo Ventures
OrbiMed Advisors
Osage University Partners
RiverVest Venture Partners
TPG Biotech
undisclosed
04/30/14 $49,000,000 Series D Ally Bridge Group
Aperture Venture Partners
Avalon Ventures
Clough Capital Partners
Domain Associates
Federated Kaufmann Funds
Jennison Associates
Novo Ventures
OrbiMed Advisors
Perceptive Advisors
RiverVest Venture Partners
TPG Biotech
undisclosed